Robert Moots

Professor of Rheumatology

Edge Hill University

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Robert Moots is a Faculty member in the Department of Rheumatology at Edge Hill University, UK. His research focuses on various aspects of rheumatology, including treatment responses in rheumatic diseases, the challenges of developing rheumatology in Sub-Saharan Africa, and the metabolic profiling of neutrophils in rheumatoid arthritis. Recent publications highlight his work on Behçet’s syndrome and the impact of comorbidities on treatment efficacy in axial spondyloarthritis.

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

Bangor University

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Robert Moots

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Developing Rheumatology in Sub-Saharan Africa: Addressing the Challenges

Predicting response to infliximab and interferon-α in Behçet’s syndrome: An exploratory analysis from the BIO-BEHÇET’S randomized controlled trial

Infliximab vs interferon-α in the treatment of Behçet’s syndrome: clinical data from the BIO-BEHÇET’S randomized controlled trial

The efficacy and safety of a fixed-dose combination of apocynin and paeonol, APPA, in symptomatic knee OA: A double-blind, randomized, placebo-controlled, clinical trial

Infliximab versus alpha interferon in the treatment of Behçet’s disease: the BIO BEHÇET’S RCT

Patients with High Baseline Neutrophil-to-Lymphocyte Ratio Exhibit Better Response to Filgotinib as Treatment for Rheumatoid Arthritis

Cutaneous signs of rheumatic diseases in skin of colour: are we failing our patients?

Metabolic Profiling of Rheumatoid Arthritis Neutrophils Reveals Altered Energy Metabolism That Is Not Affected by JAK Inhibition

Depression and anxiety symptoms at TNF inhibitor initiation are associated with impaired treatment response in axial spondyloarthritis

Comorbidity and response to TNF inhibitors in axial spondyloarthritis: longitudinal analysis of the BSRBR-AS

Internalization of Neutrophil-Derived Microvesicles Modulates TNFα-Stimulated Proinflammatory Cytokine Production in Human Fibroblast-Like Synoviocytes

Association between comorbidities and disease activity in axial spondyloarthritis: results from the BSRBR-AS

Type I interferon regulates cytokine-delayed neutrophil apoptosis, reactive oxygen species production and chemokine expression

Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis

Collaborators (5)

Graham Wallace

Alan Reynolds

David Hughes

Helen Wright

Elinor Chapman

Make your next move.